| Name | salt-inducible kinase 2 |
| Description | Enables ATP binding activity; magnesium ion binding activity; and protein kinase activity. Involved in intracellular signal transduction and protein autophosphorylation. Is active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSalt‐inducible kinase 2 (SIK2) is a multifunctional serine/threonine kinase of the AMP‐activated protein kinase family that integrates diverse extracellular cues to regulate cancer cell metabolism and cell cycle progression. In ovarian cancer, for example, adipocyte‐rich microenvironments trigger calcium‐dependent activation and autophosphorylation of SIK2, thereby enhancing both AMPK‐dependent phosphorylation of metabolic enzymes and PI3K/AKT signaling to promote metastasis and metabolic reprogramming (e.g., increased glycolysis), while its localization at centrosomes facilitates the initiation of mitosis and modulates sensitivity to taxane chemotherapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSIK2 activity is tightly regulated by a series of post‐translational modifications and protein–protein interactions. Hormonal signals—such as parathyroid hormone in osteocytes—elicit SIK2 modulation that culminates in altered expression of regulators like SOST and RANKL, impacting bone formation. In adipocytes, cAMP‐elevating agents drive PKA‐dependent phosphorylation (notably at Ser358) and 14–3–3 binding, which govern SIK2’s subcellular distribution and catalytic function. In addition, SIK2 influences CREB–mediated gene expression through interactions with class IIa histone deacetylases and is itself subject to regulation by microRNAs (e.g., miR‑874 and miR‑203) as well as degradation via ubiquitin ligases such as Fbxw7. Collectively, these regulatory mechanisms enable SIK2 to control key signaling networks that affect cell differentiation, insulin and cytokine signaling, and survival in various contexts including prostate and epithelial ovarian cancers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond these roles in primary tumorigenesis, SIK2 functions within an extensive regulatory network that influences autophagy, endoplasmic reticulum–associated degradation, and stress responses by interacting with partners such as p97/VCP and PP2A. In several malignancies—including diffuse large B‐cell, pancreatic, colorectal, gastric, hepatocellular, triple‐negative breast, and uveal melanoma—dysregulated SIK2 signaling modulates pathways such as Wnt/β‐catenin, TORC2/AKT, and TGF‑β, thereby affecting epithelial–mesenchymal transition, cytoskeletal dynamics, chemoresistance, and cell survival. Moreover, SIK2 has emerged as an important mediator in non–cancerous pathologies, regulating glucose uptake in adipocytes, maintaining mesothelial cell viability during peritoneal dialysis, and controlling pancreatic β cell proliferation and renal tubular homeostasis in diabetic kidney disease. Through its capacity to direct metabolic reprogramming, inflammatory responses, and cytoskeletal organization—even in the context of pathogen invasion—SIK2 stands out as a promising prognostic biomarker and therapeutic target across a myriad of diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fabrizio Miranda, David Mannion, Shujuan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2016.06.020"}], "href": "https://doi.org/10.1016/j.ccell.2016.06.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27478041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27478041"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ahmed Ashour Ahmed, Zhen Lu, Nicholas B Jennings, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2010.06.018"}], "href": "https://doi.org/10.1016/j.ccr.2010.06.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20708153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20708153"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Tian Gao, Xiaohong Zhang, Jing Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2019.10.029"}], "href": "https://doi.org/10.1016/j.canlet.2019.10.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31639424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31639424"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jing Zhao, Xiaohong Zhang, Tian Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-2221-x"}], "href": "https://doi.org/10.1038/s41419-019-2221-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31932581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31932581"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Marc N Wein, Yanke Liang, Olga Goransson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIKs control osteocyte responses to parathyroid hormone."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms13176"}], "href": "https://doi.org/10.1038/ncomms13176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27759007"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27759007"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Donald R Walkinshaw, Ryan Weist, Go-Woon Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.456996"}], "href": "https://doi.org/10.1074/jbc.M113.456996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23393134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23393134"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Emma Henriksson, Helena A Jones, Kashyap Patel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20111932"}], "href": "https://doi.org/10.1042/BJ20111932"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22462548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22462548"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Tim Sonntag, Joan M Vaughan, Marc Montminy "}, {"type": "b", "children": [{"type": "t", "text": "14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.14351"}], "href": "https://doi.org/10.1111/febs.14351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29211348"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29211348"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hélène Bon, Karan Wadhwa, Alexander Schreiner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-13-0182-T"}], "href": "https://doi.org/10.1158/1541-7786.MCR-13-0182-T"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25548099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25548099"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Bairong Xia, Mei Lin, Wei Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem Mol Toxicol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbt.22168"}], "href": "https://doi.org/10.1002/jbt.22168"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30004169"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30004169"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Maria Stella Lombardi, Corine Gilliéron, Damien Dietrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.2A0715-307R"}], "href": "https://doi.org/10.1189/jlb.2A0715-307R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26590148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26590148"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Fu-Chia Yang, Bertrand Chin-Ming Tan, Wei-Hao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.431239"}], "href": "https://doi.org/10.1074/jbc.M112.431239"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23322770"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23322770"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yingyi Liu, Sujie Gao, Xuebo Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-5066-2"}], "href": "https://doi.org/10.1007/s13277-016-5066-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27236538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27236538"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Johanna Säll, Annie M L Pettersson, Christel Björk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-016-4141-y"}], "href": "https://doi.org/10.1007/s00125-016-4141-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27807598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27807598"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Kimberly E Maxfield, Jennifer Macion, Hariprasad Vankayalapati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 Restricts Autophagic Flux To Support Triple-Negative Breast Cancer Survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00380-16"}], "href": "https://doi.org/10.1128/MCB.00380-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27697861"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27697861"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xiao-Man Dai, Yan-Hui Zhang, Xiao-Han Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12838"}], "href": "https://doi.org/10.1002/1878-0261.12838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33128264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33128264"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Stefan Nagel, Ellen Leich, Hilmar Quentmeier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Lymphoma (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/10428191003699878"}], "href": "https://doi.org/10.3109/10428191003699878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20367563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20367563"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yang An, Jianfang Zhao, Fangfei Nie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Parathyroid hormone (PTH) promotes ADSC osteogenesis by regulating SIK2 and Wnt4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.06.084"}], "href": "https://doi.org/10.1016/j.bbrc.2019.06.084"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31235257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31235257"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xiu Shi, Xuejiao Yu, Juan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.13208"}], "href": "https://doi.org/10.1002/1878-0261.13208"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35278271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35278271"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Fu-Chia Yang, Ya-Huei Lin, Wei-Hao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.492199"}], "href": "https://doi.org/10.1074/jbc.M113.492199"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24129571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24129571"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Chia-Wei Lee, Fu-Chia Yang, Hsin-Yun Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction between salt-inducible kinase 2 and protein phosphatase 2A regulates the activity of calcium/calmodulin-dependent protein kinase I and protein phosphatase methylesterase-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.540229"}], "href": "https://doi.org/10.1074/jbc.M113.540229"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24841198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24841198"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Zhuoxian Rong, Lu Zhang, Zhi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-022-02259-0"}], "href": "https://doi.org/10.1038/s41388-022-02259-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35277657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35277657"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Hyun Yong Jin, Yanyan Tudor, Kaylee Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "SLAS Discov (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/2472555219893277"}], "href": "https://doi.org/10.1177/2472555219893277"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31849250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31849250"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Jianghu Huang, Feiyue Lin, Chuncai Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00662 facilitates osteosarcoma progression via sponging miR-103a-3p and regulating SIK2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Tissue Eng Regen Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/term.3242"}], "href": "https://doi.org/10.1002/term.3242"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34559955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34559955"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Marcel Hahn, Adriana Covarrubias-Pinto, Lina Herhaus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 orchestrates actin-dependent host response upon "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "Salmonella"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2024144118"}], "href": "https://doi.org/10.1073/pnas.2024144118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33947818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33947818"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Luke D Hutchinson, Nicola J Darling, Stephanos Nicolaou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-inducible kinases (SIKs) regulate TGFβ-mediated transcriptional and apoptotic responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-2241-6"}], "href": "https://doi.org/10.1038/s41419-020-2241-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31969556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31969556"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Marah Armouti, Nicola Winston, Osamu Hatano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-inducible Kinases Are Critical Determinants of Female Fertility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/endocr/bqaa069"}], "href": "https://doi.org/10.1210/endocr/bqaa069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32343771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32343771"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Ming-Xia Zhang, Hao Wang, Guo-Ping Sun "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11396"}], "href": "https://doi.org/10.1002/cbin.11396"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32437091"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32437091"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Caterina Iorio, Jillian L Rourke, Lisa Wells, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing the G-protein coupled receptor 3-salt inducible kinase 2 pathway promotes human β cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Commun Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s42003-021-02433-2"}], "href": "https://doi.org/10.1038/s42003-021-02433-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34302056"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34302056"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xiaohong Ni, Yongjiang Feng, Xiangwei Fu "}, {"type": "b", "children": [{"type": "t", "text": "Role of salt‑inducible kinase 2 in the malignant behavior and glycolysis of colorectal cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2021.12460"}], "href": "https://doi.org/10.3892/mmr.2021.12460"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34558647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34558647"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "H-H Wang, C-Y Lin, S-H Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of salt-inducible kinase 2 promotes the viability of peritoneal mesothelial cells exposed to stress of peritoneal dialysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.79"}], "href": "https://doi.org/10.1038/cddis.2016.79"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27441650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27441650"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Bingyao Liu, Linlin Zhang, Hang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 protects against renal tubular injury and the progression of diabetic kidney disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.trsl.2022.08.012"}], "href": "https://doi.org/10.1016/j.trsl.2022.08.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36075517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36075517"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Yuan Li, Jinsong Yu, Manran Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Toxicol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/tox.23366"}], "href": "https://doi.org/10.1002/tox.23366"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34491613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34491613"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Sarah Proteau, Imène Krossa, Chrystel Husser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Mol Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/emmm.202317719"}], "href": "https://doi.org/10.15252/emmm.202317719"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37966164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37966164"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Florentina Negoita, Magdalena Vavakova, Johanna Säll, et al. "}, {"type": "b", "children": [{"type": "t", "text": "JUP/plakoglobin is regulated by salt-inducible kinase 2, and is required for insulin-induced signalling and glucose uptake in adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2020.109786"}], "href": "https://doi.org/10.1016/j.cellsig.2020.109786"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32966883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32966883"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Grace Kelly Lee, Hae-Yeong Kim, Jong Hwan Park "}, {"type": "b", "children": [{"type": "t", "text": "Inhibiting eukaryotic initiation factor 5A (eIF5A) hypusination attenuated activation of the SIK2 (salt-inducible kinase 2)-p4E-BP1 pathway involved in ovarian cancer cell proliferation and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-023-08510-5"}], "href": "https://doi.org/10.1007/s11033-023-08510-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37219665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37219665"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Ka-Kui Chan, Zahi Abdul-Sater, Aditya Sheth, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.13027"}], "href": "https://doi.org/10.1002/1878-0261.13027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34058059"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34058059"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Johanna Säll, Maria Lindahl, Andreas M Fritzen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salt-inducible kinases are required for glucose uptake and insulin signaling in human adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Obesity (Silver Spring) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/oby.23858"}], "href": "https://doi.org/10.1002/oby.23858"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37608474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37608474"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Qian Wu, Chang Qu, Lin Xin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIK2-positive tumor epithelial cells in breast cancer maybe potential anti-cancer messengers: A systematic analysis from a single-cell perspective."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Toxicol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/tox.23987"}], "href": "https://doi.org/10.1002/tox.23987"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37772720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37772720"}]}]}]}
|
| Synonyms | SNF1LK2, QIK, LOH11CR1I, SIK-2 |
| Proteins | SIK2_HUMAN |
| NCBI Gene ID | 23235 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SIK2 has 7,812 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 124 datasets.
Click the + buttons to view associations for SIK2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SIK2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SIK2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SIK2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SIK2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SIK2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SIK2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SIK2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SIK2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SIK2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with SIK2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SIK2 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SIK2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SIK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SIK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing SIK2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SIK2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SIK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SIK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing SIK2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing SIK2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SIK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SIK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SIK2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SIK2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SIK2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SIK2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SIK2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SIK2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SIK2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SIK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SIK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SIK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SIK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SIK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SIK2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SIK2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SIK2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SIK2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SIK2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SIK2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SIK2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SIK2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SIK2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SIK2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SIK2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SIK2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SIK2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SIK2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SIK2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SIK2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SIK2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SIK2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SIK2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SIK2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SIK2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SIK2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SIK2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SIK2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SIK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SIK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SIK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SIK2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SIK2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SIK2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SIK2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SIK2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SIK2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SIK2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SIK2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by SIK2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SIK2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SIK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SIK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SIK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate SIK2 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways 2026 | pathways involving SIK2 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate SIK2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SIK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SIK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SIK2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SIK2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS KinomeScan Kinase Inhibitor Targets | small molecules inhibiting SIK2 kinase from the KinomeScan Kinase Inhibitor Targets dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SIK2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SIK2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SIK2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SIK2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SIK2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SIK2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SIK2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SIK2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SIK2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SIK2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SIK2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SIK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SIK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SIK2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SIK2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with SIK2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate SIK2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving SIK2 protein from the PID Pathways dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SIK2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SIK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SIK2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SIK2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SIK2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SIK2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of SIK2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SIK2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SIK2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SIK2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SIK2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SIK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SIK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SIK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SIK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SIK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SIK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |